|
| | 
|
 | |
        
|  |
 
|
| PS: The quotes after 2011-04-08 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to GENZYME CORPORATI Static Chart |
 GENZYME CORPORATI - [Ticker: GENZ] |     | | Last Trade | 0.00 | Last Trade Time | - 00:00:00 | | Variation | N/A (N/A) | Open | 0.00 | | High | 0.00 | Low | 0.00 | | Volume | 0 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | N/A | | Former Close | 0.00 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
|
News about GENZYME CORPORATI [GENZ]: (ordered by relevance)
| | Metastatic Breast Cancer Patients Benefit from Targeted Therapies Matched to Genomic Alterations OncoZine
ImmunoGen Appoints Tracey L. McCain, Esq. to Its Board of Directors Business Wire
Cancer Nanomedicine Market Dynamics Analysis, Production, Supply and Demand, Covered in the Latest Research 2021-2028 Digital Journal
Viscosupplementation Market Size 2021, Share Estimation, Trend Analysis, Industry Growth Rate, Company Profiles with Strategies, Global Sales and Revenues, Future Demands, Production-Scenario and Supply Forecast 2026 Taiwan News
Movers & Shakers, July 9 | BioSpace BioSpace
Global Clinical In Vitro Diagnostic Medical Laboratory Services Markets Report 2021-2025: Focus on Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx - ResearchAndMarkets.com Business Wire
Worldwide Whole Genome and Exome Sequencing Industry to 2026 - Featuring 10x Genomics, Abbott Diagnostics and Agilent Among Others PRNewswire
Clinical Diagnostics Market is Going to Boom with Siemens Healthcare, Sonic Healthcare, Charles River Laboratories ? UK Parents Lounge UK Parents Lounge
Genzyme Ireland sees 50% growth in profits to ?65.2m The Irish Times
Aesthetic Fillers Market is Expected to Reach USD 4.6 Billion by 2027 - AllTheResearch GlobeNewswire
Harvard Business School's Baker Library Announces New Collection: John Hawkins Research Interviews about Henri Termeer, Longtime Chairman, CEO, and President of Genzyme Corporation - News Harvard Business School
Joseph Arron marches to the beat of his own drum at 23andMe; Ex-Voyager CFO joins Sek Kathiresan at Verve Therapeutics Endpoints News
Vericel Expands Executive Leadership Team and Announces Appointment of Patrick Fowler as Senior Vice President, Corporate Development and Strategy Yahoo Finance
ReForm Biologics Announces Corporate Reorganization Business Wire
Gaucher Disease Treatment Market 2021 ? 2028 | Industry In-depth Analysis By Players Genzyme Corporation, Pfizer, Inc., Shire Human Genetics Therapies, Inc. Medgadget
The Petri Dish: Former Genzyme CFO joins biologics startup - Boston Business Journal Boston Business Journal
FDA Approves New Treatment for Pompe Disease | FDA FDA.gov
Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right FierceBiotech
Sanofi is betting big on mRNA vaccines after Moderna, Pfizer see success with COVID-19 shots The Boston Globe
Sanofi approaches Genzyme for acquisition: sources Reuters
Abeona Therapeutics Appoints Gene Therapy Quality Leader Jon Voss as Vice President, Head of Quality Yahoo Finance
Sanofi-aventis buys Genzyme for $20 billion - Feb. 16, 2011 CNNMoney
Movers & Shakers, Sept. 17 | BioSpace BioSpace
Sanofi announces settlement agreement related to Contingent Value Rights (CVRs) Litigation GlobeNewswire
Potential SRT for Neuronopathic Gaucher Shows Efficacy in Early Study Gaucher Disease News
Sanofi-Aventis Completes Acquisition of Genzyme Corporation PR Newswire
M&A Objection Lawsuits and Claims for Inadequate Consideration: A ?Bumpy? Road for D&O Insurers JD Supra
Gemini Therapeutics Announces Appointment of Georges Gemayel, Ph.D. as Chair of Board of Directors Business Wire
Magenta Therapeutics Appoints Thomas Beetham as Chief Legal Officer Yahoo Finance
Henri A. Termeer Square Officially Dedicated in Cambridge Business Wire
Titan Medical Expands Senior Leadership Team Business Wire
VBI Vaccines Appoints Linda Bain to Board of Directors Business Wire
Exclusive: Relational analysis puts Genzyme value at $93/shr Reuters
| For more news about GENZYME CORPORATI click here:
GENZYME CORPORATI News |
|
Website Width:
Background image: |
|  | |
|
|
